SPRINT: Lower Blood Pressure Target May Reduce Mortality, Cardiovascular Events
Results from the SPRINT trial suggest that a systolic blood pressure target of 120 mm Hg instead of 140 mm Hg may prevent CV events.
AHA 2015
MI-GENES: Genetic Risk Information May Motivate Patients to Lower LDL Cholesterol
Disclosing genetic risk information resulted in lower LDL cholesterol levels in patients at risk for coronary heart disease.
Fewer Adults Achieving Ideal Cardiovascular Health
A decrease was noted in the number of people who score highly on 7 metrics of cardiovascular health defined by the AHA.
Energy Drinks May Spike Blood Pressure, Norepinephrine Levels
Physicians may need to ask young adults about energy drink intake in emergency settings.
Many Hispanic Patients Undertreated for High Cholesterol
Only one-third to one-half of eligible Hispanic patients studied are taking statins or other lipid-lowering therapies.
Gender Disparities Exist in Cardiovascular Care
Mortality rate is higher among women with heart disease after discharge from the hospital.
Even Young Obese Children Have Evidence of Heart Disease
Obese children as young as age 8 years have signs of heart disease and heart muscle abnormalities.
Peer Group Intervention May Thwart Cardiovascular Disease
Results from the Fifty-Fifty trial demonstrated the success of peer support in reducing cardiovascular risk factors.
Many Women Unaware of Their Risk for CVD
Many women in the United States do not feel personally connected to the risk of heart disease.
3D Printing May Lead to Personalized Pills
Personalized medications based on a patient’s medical and biological profiles may be possible with 3D printing.
Want to read more?
Please login or register first to view this content.
Next post in AHA 2015
